Literature DB >> 22842522

Oncosecretomics coupled to bioenergetics identifies α-amino adipic acid, isoleucine and GABA as potential biomarkers of cancer: Differential expression of c-Myc, Oct1 and KLF4 coordinates metabolic changes.

Nadège Bellance1, Lisa Pabst, Genevara Allen, Rodrigue Rossignol, Deepak Nagrath.   

Abstract

Bioenergetic profiling of tumors is a new challenge of cancer research and medicine as therapies are currently being developed. Meanwhile, methodological means must be proposed to gather information on tumor metabolism in order to adapt these potential therapies to the bioenergetic specificities of tumors. Studies performed on tumors and cancer cell lines have shown that cancer cells bioenergetics is highly variable. This profile changes with microenvironmental conditions (eg. substrate availability), the oncogenes activated (and the tumor suppressors inactivated) and the interaction with the stroma (i.e. reverse Warburg effect). Here, we assessed the power of metabolic footprinting (MFP) to unravel the bioenergetics and associated anabolic changes induced by three oncogenes, c-Myc, KLF4 and Oct1. The MFP approach provides a quantitative analysis of the metabolites secreted and consumed by cancer cells. We used ultra performance liquid chromatography for quantifying the amino acid uptake and secretion. To investigate the potential oncogene-mediated alterations in mitochondrial metabolism, we measured oxygen consumption rate and ATP production as well as the glucose uptake and lactate release. Our findings show that c-Myc deficiency initiates the Warburg effect along with a reduction of mitochondrial respiration. KLF4 deficiency also stimulated glycolysis, albeit without cellular respiration impairment. In contrast, Oct1 deficiency reduced glycolysis and enhanced oxidative phosphorylation efficiency. MFP revealed that c-Myc, KLF4 and Oct1 altered amino acid metabolism with specific patterns. We identified isoleucine, α-aminoadipic acid and GABA (γ-aminoisobutyric acid) as biomarkers related. Our findings establish the impact of Oct1, KLF4 and c-Myc on cancer bioenergetics and evidence a link between oncosecretomics and cellular bioenergetics profile.
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22842522     DOI: 10.1016/j.bbabio.2012.07.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Authors:  Karina Vázquez-Arreguín; Dean Tantin
Journal:  Biochim Biophys Acta       Date:  2016-02-10

2.  Effects of total gastrectomy on plasma silicon and amino acid concentrations in men.

Authors:  Marcin R Tatara; Witold Krupski; Maria Szpetnar; Andrzej Dąbrowski; Paweł Bury; Anna Szabelska; Anna Charuta; Anna Boguszewska-Czubara; Ryszard Maciejewski; Grzegorz Wallner
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-02

Review 3.  MYC and mitochondrial biogenesis.

Authors:  Fionnuala Morrish; David Hockenbery
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

4.  Non-neuronal release of gamma-aminobutyric Acid by embryonic pluripotent stem cells.

Authors:  Lin Teng; Ya-Bin Tang; Fan Sun; Shi-Min An; Chun Zhang; Xin-Jie Yang; Hao-Yu Lv; Qin Lu; Yong-Yao Cui; Jin-Jia Hu; Liang Zhu; Hong-Zhuan Chen
Journal:  Stem Cells Dev       Date:  2013-08-02       Impact factor: 3.272

5.  Tamoxifen induces a pluripotency signature in breast cancer cells and human tumors.

Authors:  George Notas; Vassiliki Pelekanou; Marilena Kampa; Konstantinos Alexakis; Stelios Sfakianakis; Aggelos Laliotis; John Askoxilakis; Eleftheria Tsentelierou; Maria Tzardi; Andreas Tsapis; Elias Castanas
Journal:  Mol Oncol       Date:  2015-06-05       Impact factor: 6.603

6.  A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.

Authors:  Taichiro Nishikawa; Nadège Bellance; Aaron Damm; Han Bing; Zhen Zhu; Kan Handa; Mladen I Yovchev; Vasudha Sehgal; Tyler J Moss; Michael Oertel; Prahlad T Ram; Iraklis I Pipinos; Alejandro Soto-Gutierrez; Ira J Fox; Deepak Nagrath
Journal:  J Hepatol       Date:  2014-02-26       Impact factor: 25.083

7.  BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism.

Authors:  Karina Vázquez-Arreguín; Jessica Maddox; Jinsuk Kang; Dongju Park; Reuben R Cano; Rachel E Factor; Thomas Ludwig; Dean Tantin
Journal:  Mol Cancer Res       Date:  2018-01-12       Impact factor: 5.852

8.  Cessation of biomechanical stretch model of C2C12 cells models myocyte atrophy and anaplerotic changes in metabolism using non-targeted metabolomics analysis.

Authors:  Amro Ilaiwy; Megan T Quintana; James R Bain; Michael J Muehlbauer; David I Brown; William E Stansfield; Monte S Willis
Journal:  Int J Biochem Cell Biol       Date:  2016-08-08       Impact factor: 5.085

Review 9.  Octamer-binding transcription factors: genomics and functions.

Authors:  Feng-Qi Zhao
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01

10.  Metabolic control analysis of respiration in human cancer tissue.

Authors:  Tuuli Kaambre; Vladimir Chekulayev; Igor Shevchuk; Kersti Tepp; Natalja Timohhina; Minna Varikmaa; Rafaela Bagur; Aleksandr Klepinin; Tiia Anmann; Andre Koit; Andrus Kaldma; Rita Guzun; Vahur Valvere; Valdur Saks
Journal:  Front Physiol       Date:  2013-06-28       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.